Journals / İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2019 / Cilt: 23 - Sayı: 2

EVALUATION OF CLINICAL CHARACTERISTICS AND MORTALITY OF KLEBSIELLA PNEUMONIAE BLOODSTREAM INFECTIONS IN A TEACHING HOSPITAL

BİR EĞİTiM VE ARAŞTIRMA HASTANESİNDE KLEBSİELLA PNEUMONİAE KAN DOLAŞIMI ENFEKSİYONLARININ KLİNİK ÖZELLİKLERİ VE MORTALİTENİN DEĞERLENDİRİLMES

Pages
75–81
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Introduction: The aim of this study was to describe clinical characteristics of Klebsiella pneumoniaebloodstream infection (KPBSI) in patients admitted to a teaching hospital and to evaluate the risk factorsrelated to overall patient mortality from those infections.Material and Method: This retrospective cohort study was conducted with hospitalized patients in a training andresearch hospital between 2012 and 2016.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The aim of this study was to describe clinical characteristics of Klebsiella pneumoniaebloodstream infection (KPBSI) in patients admitted to a teaching hospital and to evaluate the risk factorsrelated to overall patient mortality from those infections.Material and Method: This retrospective cohort study was conducted with hospitalized patients in a training andresearch hospital between 2012 and 2016.
📊
Key Findings & Data:Data were recorded to the electronic patient data monitoring system.Result: A total of 288 patients with KPBSI were identified, and 155 (53.8%) male patients ranging from 18 to 104(63.4±17.8) years old were included in the study.
💡
Conclusion & Impact:Most of the KPBSI (79.5%) were acquired in hospitals.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: The aim of this study was to describe clinical characteristics of Klebsiella pneumoniaebloodstream infection (KPBSI) in patients admitted to a teaching hospital and to evaluate the risk factorsrelated to overall patient mortality from those infections.Material and Method: This retrospective cohort study was conducted with hospitalized patients in a training andresearch hospital between 2012 and 2016. Data were recorded to the electronic patient data monitoring system.Result: A total of 288 patients with KPBSI were identified, and 155 (53.8%) male patients ranging from 18 to 104(63.4±17.8) years old were included in the study. Most of the KPBSI (79.5%) were acquired in hospitals.

Özet

Giriş: Bu çalışmanın amacı bir eğitim ve araştırma hastanesine kabul edilmiş Klebsiella pneumoniae kan dolaşımı enfeksiyonu (KPKDE) gelişen hastaların klinik özelliklerini ve bu enfeksiyonlara bağlı genel hasta mortalitesi ile ilişkili risk faktörlerini değerlendirmektir. Gereç ve Yöntem: Bu retrospektif kohort çalışması bir eğitim ve araştırma hastanesinde 2012-2016 yılları arasında yatırılarak izlenmiş hastalarla yapılmıştır. Elektronik hasta izleme sistemindeki veriler kaydedilmiştir. Bulgular: Çalışmaya KPKDE gelişmiş toplam 288 hasta dahil edilmiştir ve yaşları 18-104 aralığında olan hastaların 155 (%53.8)’i erkektir. KPKDE'nin çoğu (% 79.5) hastane kaynaklıdır. İkiyüzseksensekiz KPKDE’nin 64'ü (% 22.2) karbapeneme dirençli K. pneumoniae'ye bağlı gelişmiştir. Karbapenem direnci gelişmesi için en önemli risk faktörü antibiyotik kullanımıdır. İkiyüzseksensekiz KPKDE’nin 28 günlük mortalite oranı % 49.6’dır. Yirmisekiz günlük KPKDE mortalitesi için en önemli risk faktörü ciddi sepsistir. Sonuç: Çalışmamızda KPKDE gelişen hastaların çoğunun hastane kaynaklı enfeksiyonlar olduğunu bulduk. Mortalite için en önemli risk faktörü ciddi sepsistir. Enfeksiyon hastalıkları uzmanları, KPKDE gelişen olgularda uygun ampirik tedavinin erken dönemde başlanmasını gözönünde bulundurmalıdır.

🔖

Cite This Article

SÖNMEZ, U., ZENCİR, M., TOSUN, S., YILDIRIM, D. Y., ÇALIK, Ş., ARI, A., YİŞ, R. (2022). EVALUATION OF CLINICAL CHARACTERISTICS AND MORTALITY OF KLEBSIELLA PNEUMONIAE BLOODSTREAM INFECTIONS IN A TEACHING HOSPITAL. İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 23 - Sayı: 2, 75–81. https://ajindex.com/articles/557785

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Tian L, Tan R, Chen Y, Sun J, Liu J, Qu H, Wang X. Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: Factors related to the carbapenem resistance and patient mortality. Antimicrob Resist Infect Control 2016; 5: 48. Papadimitriou-Olivgeris M, Marangos M, Christofidou M, Fligou F, Bartzavali C, Panteli ES, et al. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit. Scand J Infect Dis 2014; 46(9): 642–8.
  2. Durdu B, Hakyemez IN, Bolukcu S, Okay G, Gultepe B, Aslan T. Mortality markers in nosocomial Klebsiella pneumoniae bloodstream infection. Springerplus 2016; 5(1): 1892. Aktaş Z, Kayacan CB, Schneider I, Can B, Midilli K, Bauernfeind A. Carbapenem- hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy 2008; 54(2): 101–106.
  3. Zarakolu P, Eser OK, Aladag E, Al-Zahrani IA, Day KM, Atmaca O, et al. Epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization: A surveillance study at a Turkish university hospital from 2009 to 2013. Diagn Microbiol Infect Dis 2016; 85(4): 466–70.
  4. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase producing Enterobacteriaceae: An emerging public-health concern. Lancet Infect Dis 2008; 8(3): 159–66.
  5. MacKenzie FM, Forbes KJ, Dorai-John T, Amyes SG, Gould IM. Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet 199;, 350(9080): 783. Akgul F, Bozkurt I, Sunbul M, Esen S, Leblebicioglu H. Risk factors and mortality in the carbapenem-resistant Klebsiella pneumoniae infection: Case control study. Pathog Glob Health 2016; 10(7–8): 321–5. Salman N. Carbapenem-resistant Klebsiella pneumoniae colonization in pediatric and neonatal intensive care units: Risk factors for progression to infection. Braz J Infect Dis 2016; 20(2): 134–40.
  6. Karabay O, Altindis M, Koroglu M, Karatuna O, Aydemir ÖA, Erdem AF. The carbapenem-resistant Enterobacteriaceae threat is growing: NDM-1 epidemic at a training hospital in Turkey. Ann Clin Microbiol Antimicrob 2016; 15: 6. Ulu-Kilic A, Alp E, Percin D, Cevahir F, Altay-Kürkçü C, Ozturk A, et al. Risk factors for carbapenem resistant Klebsiella pneumoniae rectal colonization in pediatric units. J Infect Dev Ctries 2014; 8(10): 1361–4.
  7. Balkan II, Aygün G, Aydın S, Mutcalı SI, Kara Z, Kuşkucu M, et al. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: Treatment. Int